Key result
Severely abnormal LVEF on coronary CTA linked to ~419% greater mortality risk.
Why the study?
Does the measurement of left ventricular function and volume with coronary CT angiography improve risk stratification for incident mortality in patients without known CAD?
Cohort (n=7,758)
Yes
Does the measurement of left ventricular function and volume with coronary CT angiography improve risk stratification for incident mortality in patients without known CAD?
Hazard Ratio: 5.19
p-value: p=< .001
Left ventricular dysfunction and volumes measured with cardiac CT angiography significantly augment risk prediction and discrimination for future mortality beyond traditional CAD risk factors and CAD extent.
Supports incremental risk stratification with LVEF on coronary CTA; leaves open prospective validation before routine clinical use.
PURPOSE: To assess whether gradations of left ventricular (LV) ejection fraction (LVEF) and volumes measured with coronary computed tomography (CT) would augment risk stratification and discrimination for incident mortality. MATERIALS AND METHODS: This study was approved by the institutional review board, and informed consent was obtained when required. Subjects without known coronary artery disease (CAD) who underwent cardiac CT angiography with quantitative LV measurements were categorized according to LVEF (≥ 55%, 45%-54.9%, 35%-44.9%, or <35%). LV end-systolic volume (LVESV) and LV end-diastolic volume (LVEDV) were classified as normal (≥ 90 mL) or abnormal (≥ 200 mL). CAD extent and severity was categorized as none, nonobstructive, obstructive (≥ 50%), one-vessel, two-vessel, and three-vessel or left main disease. LVEF and volumes were assessed for risk prediction and discrimination of future mortality by using Cox hazards model and receiver operating characteristic curve analysis, respectively. RESULTS: During a follow-up of 2.0 years ± 0.9, 7758 patients (mean age, 58.5 years ± 13.0; 4220 male patients [54.4%]) were studied. At multivariable analysis, worsening LVEF was independently associated with mortality for moderately (hazard ratio = 3.14, P < .001) and severely (hazard ratio = 5.19, P < .001) abnormal ejection fraction. LVEF demonstrated improved discrimination for mortality (Az = 0.816) when compared with CAD risk factors alone (Az = 0.781) or CAD risk factors plus extent and severity. At multivariable analysis of a subgroup of 3706 individuals, abnormal LVEDV (hazard ratio = 4.02) and LVESV (hazard ratio = 6.46) helped predict mortality (P < .001). Similarly, LVESV and LVEDV demonstrated improved discrimination when compared with CAD risk factors or CAD extent and severity (P < .05). CONCLUSION: LV dysfunction and volumes measured with cardiac CT angiography augment risk prediction and discrimination for future mortality.
No takes yet. Share an insight, caveat, or question.
Arsanjani et al. (2014) conducted a cohort in Without known coronary artery disease (n=7,758). Worsening left ventricular ejection fraction (LVEF) vs. Normal LVEF was evaluated on Incident mortality (HR 5.19, p=< .001). Severely abnormal left ventricular ejection fraction measured by coronary CT angiography was independently associated with increased incident mortality (HR 5.19, P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: